Skip to main content
Helmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logo
Siarhei - stock.adobe.com

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Click & View

Research Highlights

Diabetes, ITS, IDR,

Handcrafted Langerhans Islets: New Hope for Type 1 Diabetes Patients?

Our organs do a remarkable job day in and day out, without ourselves even having to think about it. Our body has its own ventilation system, a clearance system for toxins, and a system to balance energy homeostasis. But what if one of these systems…

read more

Invisible and Ultrafine – How Do Air Pollutants Impact Health?

Air pollutants can not only influence the development and progression of lung diseases but also trigger inflammation throughout the body.

read more
Environmental Health, LHI, Computational Health, ICB,

A Journey into the Secrets of Human Cells

What the Human Cell Atlas (HCA) will tell us about ourselves and how scientists at Helmholtz Munich are facilitating this revolutionizing global endeavor.

read more
Computational Health, ICB, IML,

Using AI to Combat Diseases

Artificial Intelligence (AI) is becoming increasingly crucial in medical research, and Helmholtz Munich is one of the world's leading institutions in this field. It can detect tumors as effectively as severe eye diseases.

read more
Transfer,

Empowering Innovations: From the Idea to Impactful Products

Innovations and transfer are specifically promoted at Helmholtz Munich.

read more
Environmental Health, LHI,

New hope regarding lung diseases

Lung research at Helmholtz Munich has made some spectacular breakthroughs. They could pave the way for the therapy of serious diseases.

read more
Pioneer Campus,

Pioneers of Future Medical Research

Outstanding scientists from all over the world come together at Helmholtz Munich's Pioneer Campus. They bring technologies and ideas that are ground-breaking - and thus open up entirely new perspectives for medical research.

read more
Environmental Health, IEM, Molecular Targets and Therapeutics, VIRO,

In the Battle Against Viruses

During the Corona pandemic, experts from Helmholtz Munich helped to bring the situation under control as quickly as possible. Now they are preparing for the possibility of another pandemic: with new high-tech equipment and closely interlinked…

read more
Computational Health, ITG,

Big Data at Your Bedside

Analysis of genes can help in detecting diseases at an early stage as well as in determining new drug targets for therapy. Thanks to extremely powerful data processing, the field holds great promise for advancement. Helmholtz Munich is particularly…

read more
Computational Health, AIH,

AI Transforms Blood Disease Diagnosis

In the future, blood samples from patients can be evaluated not only by specialists, but also by artificial intelligence. A team from Helmholtz Munich is laying the foundations for this.

read more
Public Engagement,

In the Front Row

Numerous renowned female researchers work at Helmholtz Munich. Ensuring that female scientists receive the best support for their careers is an important element in promoting excellence.

read more
Public Engagement,

Knowledge Fosters Health!

How do I stay healthy? What impact do my environment and lifestyle have on my health? And how can I prevent, treat, or even cure chronic diseases like diabetes, allergies, or lung diseases?

read more
Transfer,

"A startup can be just as big a success as a Leibniz Prize!"

Matthias Tschöp, CEO of Helmholtz Munich, talks about translating scientific discoveries into clinical practice, about ambitious targets, and about ideas he acquired during his time in the USA.

read more
Stem Cells, IES,

Understanding Embryonic Development

The ability to reprogram cells holds great promises for regenerative medicine. Cells from the embryo at the beginning of life divide and produce all cell types in the body. What can embryos teach us so that we can generate cells ‘à la carte’ to cure…

read more
Pioneer Campus,

Organ-on-Chip: Micro-Organs for Personalised Cell Therapy

They fit in the palm of your hand – tiny mini-labs that researchers at Helmholtz Munich want to use to shape the medicine of tomorrow. “Organ-on-chip” is the key word. This approach combines engineering and biology, not only making it easier to…

read more
Transfer, Diabetes, IDR, IDF,

Our Partnerships for a World Without Diabetes

Researchers at Helmholtz Munich are working toward a world without diabetes. They are not doing so alone, but with a network of organizations, hospitals, and pharmaceutical companies. Their goal is to use experts’ knowledge to create something new:…

read more
Environmental Health, IEM,

One Health: Climate Change Triggers Common Diseases

Rising temperatures accelerate processes: The simple rule of thumb taught in chemistry classes and known as reaction velocity-temperature-regulation, also applies in a broader sense to the effects of global warming on risk groups and sensitive…

read more
Diabetes, IDF,

Early Detection Tests for a World Without Type 1 Diabetes

At Helmholtz Munich, scientists are working to ensure that no child will have to suffer from the autoimmune disease type 1 diabetes in the future.

read more
Computational Health,

How AI is Revolutionizing Medicine

Computer systems can already independently analyze health data, learn from it and even derive therapy recommendations. Which opportunities this means for patients and what research needs to apply artificial intelligence in practice.

read more
Molecular Targets and Therapeutics, STB,

Hope in the Fight Against Parasites

Every year, millions of people fall ill with Chagas or sleeping sickness. Both diseases are caused by parasites that are spreading from tropical countries to Europe. Researchers have discovered a weak spot in those parasites, which may be a key to a…

read more
Environmental Health, IAP,

The Farm Effect

Many children suffer from asthma or allergies. Early and effective prevention of these diseases is the declared goal of science. Which research strategies do scientists pursue and what part does cow barn play in this story?

read more

Research News

New Research Findings, Stem Cells, ISF,

New Source of Stem Cells in Injury-Affected Brains of Patients

Researchers from Helmholtz Munich and the LMU have discovered that, in the case of brain injuries, specific cells in the brain become active in disease situations, exhibiting properties of neural stem cells. The authors further discovered that a…

read more
Pulmonary capillary network in human precision cut lung slices (hPCLS)
New Research Findings, Environmental Health, LHI,

Accelerating Drug Development for Lung Diseases: New Insights from Single-Cell Genomics

To mechanistically understand the root causes of lung disease, and identify drugs that target specific pathways, the scientists around Prof. Herbert Schiller and Dr. Gerald Burgstaller from Helmholtz Munich are collecting deep molecular insights from…

read more
Public Engagement, Computational Health, AIH, IML,

First "Expert Hour" at the German Bundestag: Data as a driver of innovation

Helmholtz Munich organized its first "Expert Hour" in the German Bundestag. With this new event format, Helmholtz Munich will regularly provide information on politically relevant health and research topics in the future and support work in the…

read more
Transfer, Environmental Health, LHI,

First International COPD-iNET Symposium

Redefining a Global Problem and an Urgent Need to Decipher the Disease’s Multiple Sub-Types

 

We urgently need more exchange about our findings from COPD research and clinical practice. But we need to broaden our perspective on the disease just as…

read more
Awards & Grants, Computational Health, AIH,

A New Generation of Antimicrobial Peptides

The application of artificial intelligence methods for the generation of antimicrobial peptides will be the subject of research in the Deep Optimised Generation of AntiMicrobial Peptide (DOG-AMP) project. The project will be carried out by Prof. Ewa…

read more
Public Engagement, In Media, Pioneer Campus,

BioEng24 Call for Abstracts: Engineering the Future of Health at the 2024 Conference

Leading experts and aspiring scientists in the fields of Bioengineering and Biomedical AI are gearing up for the BIOENG24 conference. In May 2024 Helmholtz Munich will welcome scientists from all around the world at the new Helmholtz Pioneer Campus…

read more
Public Engagement, In Media, Environmental Health, EPI, IEM,

Climate Change and Human Health: Findings from the Lancet Countdown Report 2023

The consequences of climate change are far-reaching and profound. Extreme weather events, such as heat waves and droughts pose a severe threat to human lives and health.

read more
New Research Findings, Diabetes, IDF,

Developing Algorithms to Predict Type 1 Diabetes in Children

Pediatricians and computer scientists join forces at the Helmholtz Munich Institute for Diabetes Research to identify children with type 1 diabetes before they develop symptoms. With the help of advanced statistics and machine learning, the…

read more
Computational Health, ITG,

Munich for Women in Science

The first "Munich for Women in Science" event is dedicated to inspiring positive change for Women in Science. The event will be hosted by Helmholtz Munich and has been organized in collaboration with the Technical University Munich (TUM), the…

read more
New Research Findings, Diabetes, IDO,

Understanding the Role of GIP in Managing Diabetes and Obesity

The increasing amount of patients with obesity and type 2 diabetes benefit greatly from the recently developed GIPR:GLP-1R co-agonists. These novel compounds lead to substantial weight loss, offering a revolutionary approach to patients worldwide.…

read more
Awards & Grants, Pioneer Campus,

Protecting Biodiversity: Genomic Monitoring Project Receives BMBF Grant

One of the pressing concerns for environmental conservation and the health of our planet is the loss of biodiversity. Due to limitations in current genomic monitoring efforts, Dr. Lara Urban and her team at Helmholtz Munich are pioneering GEBIKI, a…

read more
Awards & Grants, Computational Health, ICB,

EPIC Project: Julien Gagneur receives ERC Synergy Grant

The European Research Council (ERC) today awarded 37 particularly well-funded Synergy Grants across Europe. One of these interdisciplinary research awards went to Julien Gagneur, Group Leader at Helmholtz Munich and Professor of Computational…

read more
Dr. Kamyar Hadian and Prof. Dr. Ulrike Protzer
Awards & Grants, Molecular Targets and Therapeutics, VIRO,

Double Triumph for Helmholtz Munich: Two Researchers Honored with m4 Award from BioM

Prof. Ulrike Protzer and Dr. Kamyar Hadian and their teams from Helmholtz Munich received the prestigious Bavarian m4 Award, a recognition of their exceptional contributions to the advancement of future medicine and two different groundbreaking…

read more
Awards & Grants, Diabetes, IDO,

"Reversing the Pandemic of Obesity and Diabetes"

Heinrich Wieland Prize for Matthias Tschöp: Breakthrough in the battle against obesity and diabetes

read more
Transfer, Computational Health,

Combing AI and Chemistry: The AiChemist Program for Doctoral Researchers

The AiChemist project has officially started in September 2023 Coordinated by Helmholtz Munich the project is an Innovative Doctoral Training Network funded with 3 million euros provided by the Marie Skłodowska-Curie Actions (MSCA-DN) within the EU…

read more
New Research Findings, Computational Health, ICB,

Interpreting Large-Scale Medical Datasets

ScPoli Enables Multi-Scale Representations of Cells and Samples

 

The increasing amount of data recorded in medical research can only lead to scientific breakthroughs and essential therapies for patients if interpreted and analyzed correctly.…

read more
Awards & Grants, Diabetes, IDO,

Regulation of Energy and Glucose Metabolism: Timo Müller Honored with Minkowski Prize Awarded by the EASD

Diabetes researcher Dr. Timo Müller was honored with the 58th Minkowski Prize awarded by the EASD for his distinction manifested by publications that contribute to the advancement of knowledge concerning diabetes.

read more
Transfer, Environmental Health, EPI,

Noise2NAKOAI: What AI and Machine Learning Tell Us About the Link Between Environment and Human Health

Our health and the environment around us are profoundly intertwined. But how do air pollution and other environmental factors interact with each other and determine our health for each individual and the neighborhood? Furthermore, how can artificial…

read more
Awards & Grants, Diabetes,

Diabetes Experts of Tomorrow Meet at the Helmholtz Diabetes Conference 2023

The 10th Helmholtz Diabetes Conference was a great success. From the 27th till the 29th of September about 200 diabetes experts from all over the world gathered in Munich to exchange ideas and new research findings in the field of type 1 and type 2…

read more
Awards & Grants, Diabetes, IDC,

Combating Diabetes Complications: Stephan Herzig Awarded with the Camillo Golgi Prize from the EASD

Prof. Stephan Herzig has been awarded the 38th Camillo Golgi Prize for his outstanding contributions to the histopathology, pathogenesis, prevention, and treatment of the complications of diabetes. The prize is delivered by the European Association…

read more

Our Research Centers

Helmholtz Diabetes Center

Computational Health Center

Stem Cell Center

Environmental Health Center

Bioengineering Center

Molecular Targets and Therapies Center

Helmholtz Pioneer Campus

Core Facilities

Core Facilities

Core facilities support and enable our center’s research by providing centralized access to cutting-edge technologies, instruments and highly skilled staff, fostering innovation and connecting scientists across disciplines.

Helmholtz Munich / Matthias Balk

Transfer

©Helmholtz Munich / Ertürk lab

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
n addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

More information

Our Researchers

Stephan Herzig

"It is my vision to successfully drive a mechanistic finding into clinical application in the area of obesity-related metabolic dysfunction as well as cancer cachexia."

to Stephan's page

Prof. Dr. Stephan Herzig

Director of the Diabetes Center

Fabian Theis

"With AI we can imagine a future where diagnosing and treating diseases is more affordable, widely available, and thus more democratic."

to Fabian's page

Prof. Dr. Fabian Theis

Director of the Computational Health Center

Vasilis Ntziachristos

"Our research at Helmholtz Munich is driven by our interest to provide solutions that address critical unmet medical need and positively impact healthcare and the well-being of society."

Prof. Dr. Vasilis Ntziachristos

Director of the Bioengineering Center

Erika von Mutius

"I am a passionate pediatrician scientist. My research focusses on the roots of asthma and allergy development with the aim of ultimately preventing these diseases in children at risk."

to Erika´s page

Prof. Dr. Erika von Mutius

Director of the Environmental Health Center

Magdalena Götz

"My vision is to explore the mechanisms of neurogenesis to use it for instructing neurogenesis for replacement of lost neurons."

Prof. Dr. Magdalena Götz

Director of the Stem Cell Center

Michael Sattler

"We combine integrative structural biology to elucidate molecular mechanisms of biological pathways, highlighting the essential roles of dynamics and transient regulatory interations to enable innovative structure-based drug discovery."

to Michael´s page

Prof. Dr. Michael Sattler

Director of the Molecular Targets & Therapeutics Center

Networks

Helmholtz

German Center for Diabetes Research

German Center for Lung Research